StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note published on Thursday. The brokerage issued a sell rating on the medical technology company’s stock.

Several other equities research analysts have also issued reports on the stock. Benchmark reaffirmed a speculative buy rating and set a $0.40 price target on shares of BIOLASE in a report on Wednesday. Ascendiant Capital Markets cut their target price on shares of BIOLASE from $3.50 to $2.00 and set a buy rating on the stock in a research report on Tuesday, September 3rd.

BIOLASE Price Performance

NASDAQ BIOL opened at $0.02 on Thursday. The business has a fifty day moving average price of $0.06 and a two-hundred day moving average price of $0.11. The stock has a market capitalization of $501,105.00, a PE ratio of 0.00 and a beta of 0.67. BIOLASE has a fifty-two week low of $0.02 and a fifty-two week high of $1.94.

BIOLASE (NASDAQ:BIOL) last announced its quarterly earnings data on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share for the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 41.65%. The business had revenue of $11.56 million for the quarter.

Institutional Trading of BIOLASE

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC increased its holdings in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the period. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 at the end of the most recent quarter. Institutional investors and hedge funds own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.